FDA — authorised 29 August 2017
- Application: NDA209776
- Marketing authorisation holder: REMPEX
- Local brand name: VABOMERE
- Indication: POWDER — INTRAVENOUS
- Status: approved
🇺🇸 Vabomere in United States
FDA authorised Vabomere on 29 August 2017
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Vabomere approved in United States?
Yes. FDA authorised it on 29 August 2017; FDA has authorised it.
Who is the marketing authorisation holder for Vabomere in United States?
REMPEX holds the US marketing authorisation.